Nikita Rosendahl

7PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsDeep learningSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 23, 2025
Human cDC1 enhance cytotoxic function of CD226+ terminally exhausted tumor-infiltrating lymphocytes.

Liam O'Brien, Irina Buckle, Ingrid M Leal-Rojas

|Apr 19, 2022
Characteristics, treatment and outcomes of 589 melanoma patients documented by 27 general practitioners on the Skin Cancer Audit Research Database.

Jeremy Hay, Jeff Keir, Clara Jimenez Balcells

|Oct 16, 2021
Conventional type 1 dendritic cells (cDC1) as cancer therapeutics: challenges and opportunities.

Phillip Johnson, Nikita Rosendahl, Kristen J Radford

|Aug 23, 2021
Characteristics of 637 melanomas documented by 27 general practitioners on the Skin Cancer Audit Research Database.

Clara Jimenez Balcells, Jeremy Hay, Jeff Keir

Pageof 2